Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Dialysis Patients: A Nationwide Data Survey and Propensity Analysis

Long-term benefit of using a renin–angiotensin–aldosterone system blocker such as an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin II receptor blocker (ARB) for patients already receiving dialysis remains undetermined. The aim of this study is to assess the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Cho-Kai, Yang, Yao-Hsu, Juang, Jyh-Ming Jimmy, Wang, Yi-Chih, Tsai, Chia-Ti, Lai, Ling-Ping, Hwang, Juey-Jen, Chiang, Fu-Tien, Chen, Pau-Chung, Lin, Jiunn-Lee, Lin, Lian-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602640/
https://www.ncbi.nlm.nih.gov/pubmed/25621694
http://dx.doi.org/10.1097/MD.0000000000000424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602640/
https://www.ncbi.nlm.nih.gov/pubmed/25621694
http://dx.doi.org/10.1097/MD.0000000000000424

Ejemplares similares